EUVIMEDEUVIMED entdecken
Crossref

Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis

Rawan Elkurdi, Marie F Grill, Adrijana Kekic, Janis E Blair iD

Medical Mycology · 2024

DOI: 10.1093/mmy/myae113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Rawan Elkurdi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Coccidioidomycosis, Antifungal Agents, Meningitis, Fungal, Pharmacogenomic Testing. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coccidioidomycosis can cause severe meningitis, requiring lifelong treatment. In this study, we sought to better understand the potential effect of pharmacogenomic testing on treatment outcomes of patients with coccidioidal meningitis. Of 13 patients with coccidioidal meningitis who underwent pharmacogenomic testing, 11 had genetic variants of CYP2C19 and CYP3A5 that affect antifungal efficacy. These results led to real-time treatment changes and future antifungal planning. Routine pharmacogenomic testing helps to avoid antifungal treatments that are futile or lead to adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoccidioidomycosisAntifungal AgentsMeningitis, FungalPharmacogenomic TestingHumansMaleFemaleMiddle AgedAdultAgedCytochrome P-450 CYP2C19Treatment OutcomeYoung Adult

Stichwörter der Autor:innen

antifungal treatmentcoccidioidal meningitiscoccidioidomycosispharmacogenomics

Substanzen

Antifungal AgentsCytochrome P-450 CYP2C19CYP2C19 protein, human

Autor:innen und Institutionen

  • Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.
  • University of Arizona, Banner - University Medical Center, Phoenix, Arizona, USA.
  • Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
  • Pharmacy Services, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Janis E Blair

Förderung

  • Mayo Clinic

Zitieren

APA

Elkurdi, R., Grill, M. F., Kekic, A., & Blair, J. E. (2024). Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis. Medical Mycology. https://doi.org/10.1093/mmy/myae113

Vancouver

Elkurdi R, Grill MF, Kekic A, Blair JE. Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis. Medical Mycology. 2024. doi:10.1093/mmy/myae113

BibTeX
@article{Elkurdi2024,
  author = {Elkurdi, Rawan and Grill, Marie F and Kekic, Adrijana and Blair, Janis E},
  title = {Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae113}
}
Kostenlos starten →